GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bharat Immunologicals & Biologicals Corp Ltd (BOM:524663) » Definitions » Cyclically Adjusted Book per Share

Bharat Immunologicals & Biologicals (BOM:524663) Cyclically Adjusted Book per Share : ₹14.15 (As of Sep. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Bharat Immunologicals & Biologicals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bharat Immunologicals & Biologicals's adjusted book value per share for the three months ended in Sep. 2023 was ₹18.228. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹14.15 for the trailing ten years ended in Sep. 2023.

During the past 12 months, Bharat Immunologicals & Biologicals's average Cyclically Adjusted Book Growth Rate was 9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-30), Bharat Immunologicals & Biologicals's current stock price is ₹29.61. Bharat Immunologicals & Biologicals's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was ₹14.15. Bharat Immunologicals & Biologicals's Cyclically Adjusted PB Ratio of today is 2.09.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bharat Immunologicals & Biologicals was 9.42. The lowest was 1.64. And the median was 2.61.


Bharat Immunologicals & Biologicals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Bharat Immunologicals & Biologicals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bharat Immunologicals & Biologicals Cyclically Adjusted Book per Share Chart

Bharat Immunologicals & Biologicals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 9.08 11.95 13.52

Bharat Immunologicals & Biologicals Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.96 - 13.52 - 14.15

Competitive Comparison of Bharat Immunologicals & Biologicals's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Bharat Immunologicals & Biologicals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bharat Immunologicals & Biologicals's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bharat Immunologicals & Biologicals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bharat Immunologicals & Biologicals's Cyclically Adjusted PB Ratio falls into.



Bharat Immunologicals & Biologicals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bharat Immunologicals & Biologicals's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book= Book Value per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=18.228/151.4920*151.4920
=18.228

Current CPI (Sep. 2023) = 151.4920.

Bharat Immunologicals & Biologicals Quarterly Data

Book Value per Share CPI Adj_Book
201312 0.000 91.425 0.000
201403 9.210 91.425 15.261
201406 0.000 94.103 0.000
201409 0.000 96.780 0.000
201412 0.000 96.780 0.000
201503 9.568 97.163 14.918
201506 0.000 99.841 0.000
201509 8.265 101.753 12.305
201512 0.000 102.901 0.000
201603 8.129 102.518 12.012
201606 0.000 105.961 0.000
201609 8.399 105.961 12.008
201612 0.000 105.196 0.000
201703 9.669 105.196 13.924
201706 0.000 107.109 0.000
201709 8.681 109.021 12.063
201712 0.000 109.404 0.000
201803 8.683 109.786 11.981
201806 0.000 111.317 0.000
201809 7.912 115.142 10.410
201812 0.000 115.142 0.000
201903 7.105 118.202 9.106
201906 0.000 120.880 0.000
201909 5.023 123.175 6.178
201912 0.000 126.235 0.000
202003 4.742 124.705 5.761
202006 0.000 127.000 0.000
202009 3.664 130.118 4.266
202012 3.225 130.889 3.733
202103 7.884 131.771 9.064
202106 0.000 134.084 0.000
202109 24.706 135.847 27.551
202112 24.629 138.161 27.005
202203 24.399 138.822 26.626
202206 0.000 142.347 0.000
202209 22.527 144.661 23.591
202212 0.000 145.763 0.000
202303 20.429 146.865 21.073
202306 0.000 150.280 0.000
202309 18.228 151.492 18.228

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Bharat Immunologicals & Biologicals  (BOM:524663) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bharat Immunologicals & Biologicals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=29.61/14.15
=2.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bharat Immunologicals & Biologicals was 9.42. The lowest was 1.64. And the median was 2.61.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bharat Immunologicals & Biologicals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Bharat Immunologicals & Biologicals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bharat Immunologicals & Biologicals (BOM:524663) Business Description

Traded in Other Exchanges
N/A
Address
Village Chola, BIBCOL, OPV Plant, Bulandshahar, UP, IND, 203203
Bharat Immunologicals & Biologicals Corp Ltd is an India-based biotechnology company. It primarily manufactures Oral polio vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). It also manufactures nutraceuticals and biological products for the treatment of health deficiencies and disorders. The firm is organized into three segments: Oral Polio Vaccine, Zinc Tablets, and BIB VIT, BIBSANIT. The group principally operates in India and generates the majority of its revenue from sales of Oral polio vaccines.

Bharat Immunologicals & Biologicals (BOM:524663) Headlines

No Headlines